Clinical trial
Fetched
Post
clinicaltrials.gov
Daniel Coury, Patient-Centered Outcomes Research Institute, University of California, Irvine, Holland Bloorview Kids Rehabilitation Hospital, University of Rochester, Nationwide Children's Hospital, Children's Hospital Medical Center, Cincinnati, University of Virginia, et al.
(2023).
AWARE: Management of ADHD in Autism Spectrum Disorder.
ClinicalTrials.gov.
Daniel Coury.
- Publication date
-
1 Oct 2023
- Identifier
-
NCT05916339
- Authors
-
Daniel Coury,
Patient-Centered Outcomes Research Institute,
University of California, Irvine,
Holland Bloorview Kids Rehabilitation Hospital,
University of Rochester,
Nationwide Children's Hospital,
Children's Hospital Medical Center, Cincinnati,
University of Virginia,
University of Alberta,
Massachusetts General Hospital,
MaineHealth,
University of Michigan,
University of Pittsburgh,
Children's Hospital of Philadelphia,
Children's Hospital Los Angeles
- Source
- ClinicalTrials.gov
- Reference type
- clinical_trial
- Publisher
- Daniel Coury
- Metadata source
- clinicaltrials.gov
Abstract
This study is a pragmatic clinical trial examining the comparative effectiveness of two stimulant medications (methylphenidate and amphetamine) in the treatment of ADHD in children and adolescents with autism. Using a sequential, multiple assignment randomization trial (SMART) design the study will not only assess these two medications but also the role of an increasingly popular class of ADHD medication, the alpha-2 agonists. Findings from this study will help improve clinicians' approach to medication selection and reduce the repeated trials of multiple medications that are current standard care.